These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28810648)

  • 1. Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells
    Yamaguchi M; Levy RM
    Exp Ther Med; 2017 Aug; 14(2):1769-1774. PubMed ID: 28810648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells.
    Uchiyama S; Yamaguchi M
    J Cell Biochem; 2007 Jun; 101(3):529-42. PubMed ID: 17295206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
    Yamaguchi M; Moore TW; Sun A; Snyder JP; Shoji M
    Integr Biol (Camb); 2012 Aug; 4(8):905-13. PubMed ID: 22751853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
    Van Bezooijen RL; Papapoulos SE; Löwik CW
    Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
    Blair HC; Jordan SE; Peterson TG; Barnes S
    J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
    Zhang J; Park J; Lee JW; Kwon YD; Kim EC
    Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
    Yamaguchi M; Uchiyama S
    Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis.
    Yamaguchi M
    Mol Cell Biochem; 2012 Jul; 366(1-2):201-21. PubMed ID: 22476903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression.
    Karieb S; Fox SW
    J Cell Biochem; 2011 Feb; 112(2):476-87. PubMed ID: 21268069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecules which are involved in osteoclastic bone resorption: from the aspect of targets of treatment for osteoporosis].
    Take I; Takahash N; Kurihara S
    Clin Calcium; 2005 May; 15(5):741-6. PubMed ID: 15876734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M; Futaki N; Harada M; Kaku S
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast proliferation and maturation by bisphosphonates.
    Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
    Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
    Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
    Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
    Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
    Karieb S; Fox SW
    Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.
    Kim YH; Kim GS; Jeong-Hwa B
    Exp Mol Med; 2002 May; 34(2):145-51. PubMed ID: 12085990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
    Caudrillier A; Hurtel-Lemaire AS; Wattel A; Cournarie F; Godin C; Petit L; Petit JP; Terwilliger E; Kamel S; Brown EM; Mentaverri R; Brazier M
    Mol Pharmacol; 2010 Oct; 78(4):569-76. PubMed ID: 20584969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone disease in nephropathic cystinosis is related to cystinosin-induced osteoclastic dysfunction.
    Claramunt-Taberner D; Flammier S; Gaillard S; Cochat P; Peyruchaud O; Machuca-Gayet I; Bacchetta J
    Nephrol Dial Transplant; 2018 Sep; 33(9):1525-1532. PubMed ID: 29365190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.